Task: Answer the multiple-choice question.
Question: Which drug exhibits a -49.668% human ether-à-go-go related gene (hERG) inhibition at 10uM?
Constraint: You must select none, one or more options from a or b without using any other words.
Options:
(a) Cc1c(C(=O)N(C)Cc2cccc(F)c2)oc2c(Cl)cccc12
(b) CCN(CC)C(=O)CSc1nc2ccccc2c(=O)n1CCC(=O)N1CCN(c2ccccc2)CC1
Answer: b. CCN(CC)C(=O)CSc1nc2ccccc2c(=O)n1CCC(=O)N1CCN(c2ccccc2)CC1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCN(CC)C(=O)CSc1nc2ccccc2c(=O)n1CCC(=O)N1CCN(c2ccccc2)CC1
CCN(CC)C(=O)CSc1nc2ccccc2c(=O)n1CCC(=O)N1CCN(c2ccccc2)CC1
N,N-diethyl-2-[4-oxo-3-[3-oxo-3-(4-phenylpiperazin-1-yl)propyl]quinazolin-2-yl]sulfanylacetamide